Monte Rosa Therapeutics, Inc.
GLUE
$4.59
-$0.23-4.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.88% | -12.38% | 53.66% | -7.63% | 35.93% |
| Total Receivables | 68.32% | 713.87% | -70.92% | -93.95% | 1,537.60% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.49% | -6.25% | -39.26% | 44.06% | 5.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -9.88% | -11.96% | 50.25% | -9.60% | 39.62% |
|
|
|||||
| Total Current Assets | -9.88% | -11.96% | 50.25% | -9.60% | 39.62% |
| Net Property, Plant & Equipment | -1.57% | -1.27% | -4.24% | -3.82% | -2.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.41% | 6.87% | -1.76% | -0.16% | -3.37% |
| Total Assets | -8.55% | -10.38% | 39.24% | -8.44% | 29.00% |
|
|
|||||
| Total Accounts Payable | -13.99% | -62.31% | 332.76% | -38.54% | -5.20% |
| Total Accrued Expenses | 3.28% | -23.10% | 11.85% | 27.65% | 26.37% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.92% | 4.07% | 1.87% | 5.04% | 3.77% |
| Total Finance Division Other Current Liabilities | -46.15% | -69.32% | 496.34% | -6.37% | -4.30% |
| Total Other Current Liabilities | -46.15% | -69.32% | 496.34% | -6.37% | -4.30% |
| Total Current Liabilities | -29.32% | -62.27% | 276.90% | -1.67% | 2.55% |
|
|
|||||
| Total Current Liabilities | -29.32% | -62.27% | 276.90% | -1.67% | 2.55% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.53% | -2.57% | -2.62% | -2.04% | -2.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -39.41% | 4.91% | -28.93% | -22.87% | 16.44% |
| Total Liabilities | -22.48% | -45.30% | 96.85% | -8.22% | 4.57% |
|
|
|||||
| Common Stock & APIC | 0.78% | 0.80% | 0.77% | 0.66% | 18.52% |
| Retained Earnings | -3.14% | 10.69% | 2.97% | -5.57% | -7.62% |
| Treasury Stock & Other | -1.32% | 0.80% | -44.53% | 13.03% | 0.85% |
| Total Common Equity | -2.57% | 23.43% | 8.51% | -8.55% | 47.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.57% | 23.43% | 8.51% | -8.55% | 47.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.57% | 23.43% | 8.51% | -8.55% | 47.31% |
|
|
|||||